Stryker Down Over 7%, On Pace for Largest Percent Decrease Since April 2022 — Data Talk
Stryker Corporation (SYK) is currently at $280.99, down $22.14 or 7.3%
--Would be lowest close since Nov. 10, 2023, when it closed at $273.62
--On pace for largest percent decrease since April 22, 2022, when it fell 8.04%
--Currently down eight of the past nine days
--Currently down six consecutive days; down 15.03% over this period
--Longest losing streak since March 25, 2026, when it fell for seven straight trading days
--Worst six day stretch since the six days ending March 23, 2020, when it fell 23.01%
--Down 13.22% month-to-date
--Down 20.05% year-to-date
--Down 30.37% from its all-time closing high of $403.53 on July 25, 2025
--Down 28.46% from 52 weeks ago (Sept. 9, 2025), when it closed at $392.76
--Down 28.46% from its 52-week closing high of $392.76 on Sept. 9, 2025
--Would be a new 52-week closing low
--Traded as low as $275.10; lowest intraday level since Nov. 10, 2023, when it hit $266.93
--Down 9.25% at today's intraday low; largest intraday percent decrease since April 1, 2020, when it fell as much as 13.66%
--Second worst performer in the S&P 500 today
All data as of 12:14:53 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 08, 2026 12:31 ET (16:31 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
